Searchable abstracts of presentations at key conferences in endocrinology

ea0007p283 | Clinical case reports | BES2004

A case of undiagnosed multiple endocrine neoplasia type 2B (MEN 2B)

Myint K , Wiles A , Marker A , Jani P , Middleton S , Chatterjee V , Gurnell M

Multiple Endocrine Neoplasia Type 2B is a dominantly inherited disorder characterised by mucosal neuromas, medullary thyroid carcinoma (MTC), phaeochromocytoma, and intestinal ganglioneuromatosis. We report the case of a 34-year-old woman who presented with chronic diarrhoea. She had a longstanding history of gastrointestinal symptoms including diarrhoea since the age of 7 and had been investigated extensively for over 20 years at three different centres, but no definitive dia...

ea0005p193 | Reproduction | BES2003

Maternal and neonatal outcomes after conception during cabergoline therapy for hyperprolactinaemia

Booth S , Philip S , Middleton M , Park C , Abraham P , Bevan J

Background: Since receiving its UK licence in 1994, cabergoline [CAB] has become the dopamine agonist of choice for the management of hyperprolactinaemia in most UK endocrine units. Aim: To review the outcomes for the mother and neonate when CAB is taken during conception and into early gestation. Method: Retrospective review of Aberdeen casenotes from all hyperprolactinaemic women of childbearing age on CAB therapy and those of their live born infants. Results: Twenty women w...